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ABSTRACT
LAGLIDADG homing endonucleases (LHEs) are a
family of highly specific DNA endonucleases capable
of recognizing target sequences  20bp in length,
thus drawing intense interest for their potential
academic, biotechnological and clinical applica-
tions. Methods for rational design of LHEs to
cleave desired target sites are presently limited by
a small number of high-quality native LHEs to serve
as scaffolds for protein engineering—many are un-
satisfactory for gene targeting applications. One
strategy to address such limitations is to identify
close homologs of existing LHEs possessing
superior biophysical or catalytic properties. To test
this concept, we searched public sequence data-
bases to identify putative LHE open reading
frames homologous to the LHE I-AniI and used a
DNA binding and cleavage assay using yeast
surface display to rapidly survey a subset of the
predicted proteins. These proteins exhibited a
range of capacities for surface expression and
also displayed locally altered binding and cleavage
specificities with a range of in vivo cleavage
activities. Of these enzymes, I-HjeMI demonstrated
the greatest activity in vivo and was readily crys-
tallizable, allowing a comparative structural
analysis. Taken together, our results suggest that
even highly homologous LHEs offer a readily
accessible resource of related scaffolds that
display diverse biochemical properties for biotech-
nological applications.
INTRODUCTION
LAGLIDADG homing endonuclease (LHE) genes are
mobile genetic elements that code for rare cleaving DNA
enzymes, which in turn are responsible for catalyzing their
mobility, known as homing. The homing process relies on
the generation of DNA double strand breaks in an allele
lacking the LHE gene insertion, which stimulates homolo-
gous recombination (HR) using the LHE-containing allele
as the template (1,2). As an LHE’s physiological recogni-
tion sequence is  20bp in length, it appears on average
only once every  10
12 bases. Even after accounting for an
LHE’s promiscuity at individual DNA bp positions, the
overall speciﬁcity of these enzymes appears to be at least
approximately one in 10
9. Consequently, LHEs have
drawn attention as rare cleaving nucleases for use in
diverse site-speciﬁc genome engineering applications, par-
ticularly for organisms with large genomes (3–5).
An important limitation to widespread application of
LHEs in genome engineering is the requirement to
modify a starting native LHE (‘scaffold’) to create
variants of that scaffold that cleave at speciﬁc desired
target sites. Although computational design methods
and selection protocols for this purpose are now quite
advanced (6–10), it remains challenging to consistently
produce variants with high levels of in vivo activity. One
constraint on present approaches for engineering LHE’s is
their narrow application to a small set of previously
reported, well characterized, native LHE scaffolds:
I-SceI, I-CreI, I-DmoI, I-AniI and I-OnuI (11–15).
We hypothesized that because members of this small
group were not originally identiﬁed based on speciﬁc
biotechnologically useful properties, that homologous
proteins might represent a source of closely related scaf-
folds that possess a desirable range of such properties.
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databases to identify open reading frames (ORFs)
encoding proteins homologous to the LHE I-AniI and
surveyed the properties of a subset of these proteins.
Individual proteins were assessed using an assay that
relies upon yeast surface display and that reports upon
protein folding, expression, DNA binding and cleavage
(15,16). Each of these properties can then be assayed by
ﬂow cytometric analysis in high throughput, detecting
binding or cleavage of ﬂuorescently labeled oligonucleo-
tides. A separate in vivo genome engineering reporter
assay was then used to measure targeted gene modiﬁcation
activity in transfected human cells (16–18). These analyses
revealed that I-AniI’s close homologs exhibit a broad spec-
trum of in vitro and in vivo activities. The best-performing
enzyme in this group, I-HjeMI, was readily expressed,
puriﬁed and crystallized, facilitating a comparative struc-
tural analysis of the two enzyme scaffolds. These results
delineate a robust approach for identifying related LHE
scaffolds and illustrate the value of this approach for iden-
tifying scaffolds with optimal biotechnological properties.
MATERIALS AND METHODS
Yeast surface display expression constructs and ﬂow
cytometric expression analysis
The ability of an LHE to bind and cleave a broad panel of
DNA target sequences can be readily assayed using
enzyme constructs that are displayed on the surface of
yeast, as described in Jarjour et al. (16). Yeast surface
display of I-AniI homologs on EBY100 Saccharomyces
cerevisiae was achieved using the standard vector back-
bones and methods described previously (17). Putative
LHE ORF sequences were selected, corresponding to
full-length I-AniI beginning three to four amino acids
before the ﬁrst LAGLIDADG helix. Corresponding
DNA sequences were synthesized and cloned into the
pETCON2 vector (map available on addgene.org)
between N-terminal hemagglutinin (HA) tag and
C-terminal Myc tag coding sequences using NheI and
XbaI; clones were veriﬁed by sequencing. Accession
numbers for the protein sequences of I-AchMI, I-HjeMI,
I-PnoMI, I-TasMIP, I-TinMIP and I-VinIP are
AAX34413, BK008014, ABU49435, BK008015,
BK008016 and AAB95258, respectively. Strains harboring
these vectors were grown in media containing 2% rafﬁn-
ose+0.1% glucose at 30 C for 1day before induction in
2% galactose for 2–3h at 30 C and 18–26h at 20 C. To
measure expression levels, 10
6 cells were washed in yeast
staining buffer (YSB): 180mM KCl, 10mM NaCl, 0.2%
bovine serum albumin (BSA), 0.1% galactose and 10mM
Hepes, pH 7.5. Cells were thenstained with a1:100 dilution
of ICL Labs’ aMyc-FITC antibody and a 1:250 dilution of
biotinylated aHA (Covance) antibody in YSB for 30min
at 4 C. Cells were washed and counterstained with
streptavidin–PE (BD Biosciences) in YSB for 15min at
25 C, washed again and run on a BD LSRII
TM cytometer
(BD Biosciences). The output was analyzed using FloJo
software (Tree Star) for the percentage FITC-positive
cells when compared with an unstained population.
Immunoprecipitation and western blot of surface-released
protein
Approximately 250 million expressing yeast cells (induced
as above) were harvested, washed twice in 1 phosphate-
buffered saline (PBS, Thermo Scientiﬁc) and incubated for
1h at 30 C in 1ml2mM dithiothreitol in PBS with
protease inhibitor (complete mini EDTA free, Roche) to
liberate the LHEs; this is accomplished by reducing the
disulﬁde bond anchoring the Aga2P-LHE fusion to the
surface expressed Aga1P protein (Supplementary Figure
S5). The release reaction was quenched with 10mM
iodoacetamide for 10min at 25 C to allow subsequent
immunoprecipitation. The LHE-containing supernatant
was incubated with 1:100 monoclonal rabbit aHA
antibody (C29F4, Cell Signaling) for 1h at 4 C and
precipitated with protein A-conjugated Sepharose (GE
Healthcare) by incubation overnight at 4 C. Samples
were treated with PNGaseF (New England BioLabs) ac-
cording to the manufacturer’s protocol to remove glycosyl
residues and allow proper migration on a gel. Samples
were prepared by boiling in 1  Laemmli buffer (Bio-Rad).
Denaturing polyacrylamide gel electrophoresis and
western blot to a polyvinylidene ﬂuoride membrane were
performed using standard protocols. The blot was stained
with a 1:1000 dilution of rabbit aHA antibody (Cell
Signaling), washed and counter-stained with a 1:5000
dilution of donkey aRabbit, horseradish peroxidase
antibody (GE Healthcare) for imaging with the ECL
system using Kodak Biomax light ﬁlm.
Flow cytometric cleavage assay, end-holding and
speciﬁcity proﬁling
The catalytic activity of each LHE was measured by
tethering Alexa647-ﬂuorescent target dsOligo to the sur-
face expressed LHE and measuring the decrease in ﬂuor-
escence associated with dsOligo cleavage. Biotinylated
ﬂuorescent dsOligo is tethered to the HA epitope via an
antibody-streptavidin bridge. Approximately 5 10
5 cells
were ﬁrst stained with 1:250 dilution biotinylated aHA
(Covance) and 1:100 ﬂuorescin isothiocyanate (FITC)-
conjugated aMyc (ICL Labs) for 30min at 4 C in the
YSB. Preconjugated streptavidin–PE:Biotin-dsOligo-
A467 was then bound to the yeast via the HA–biotin–
streptavidin–PE interaction. This secondary stain was per-
formed in the same buffer plus 400mM KCl to allow
biotin–streptavidin conjugation while disallowing the
LHE to bind the dsOligo directly. Cells were washed
in the cleavage solution: 10mM NaCl, 113mM
K-Glutamate, 0.05% BSA and 10mM HEPES and
pH 8.2. Cells were resuspended in the cleavage buffer
and split into two wells each. Each pair of wells were
centrifuged and resuspended in cleavage buffer plus
2mM either MgCl2 (cleavage permissive) or CaCl2
(cleavage restrictive); ﬂuorescence loss due to
magnesium-dependent cleavage of the dsOligo can subse-
quently be measured in these otherwise identical sample
pairs. After a 20-min cleavage incubation at 37 C, cells
were pelleted and resuspended in cold secondary stain
buffer plus 4mM EDTA to aid release of cleaved
substrate and mitigate any end-holding effects on
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end-holding was determined by an increased loss in ﬂuor-
escence when the ﬂuorophore was conjugated to the plus
half of the DNA substrate compared with when it was
conjugated to the minus half during the ﬂow cleavage
assay; the ﬁnal high-salt wash was not performed.
Sample ﬂuorescence was measured on a BD LSRII
TM
cytometer, and the resulting data were analyzed using
Flowjo. Each sample was normalized for enzyme concen-
tration by applying an identical narrow FITC gate. Cells
were then controlled for initial substrate concentration by
adjusting a narrow PE gate for each non-cleaving Ca
+ +
sample until the median A647 ﬂuorescence intensity was
matched for all samples. Relative cleavage efﬁciencies
were derived for this normalized population by dividing
the median DNA-A647 ﬂuorescence value of the Mg
+ +
sample (reduced ﬂuorescence due to cleavage) by the cor-
responding median ﬂuorescence value of the Ca
+ +
matched pair (no cleavage). Higher Ca
+ +/Mg
+ + ratios
indicate more cleavage.
Speciﬁcity proﬁles were produced by determining
cleavage of each of the 60 possible target sequences
wherein each base at each of the 20 positions was
substituted with each of the alternate three bases, as in
Jarjour et al.’s (17) original description of this assay. In
these experiments, all Ca
+ +/Mg
+ + ratios were normalized
to the Ca
+ +/Mg
+ + ratio of the native target site.
Assessment of in vivo gene modiﬁcation activity
Each LHE’s target site was ligated into the truncated
green ﬂuorescent protein (GFP) of the trafﬁc light
reporter (18) using annealed, phosphorylated dsOligo
(Supplementary Figure S1a). Lentivirus containing this
construct was used to transduce HEK 293T cells at
limiting dilution to obtain a population of cells with
single copy chromosomal integration events. Cells were
sorted against GFP and mCherry ﬂuorescence to ensure
that the reported started in the ‘off’ state. Endonuclease
expression/GFP repair template vectors were generated by
cloning each LHE from the yeast surface display vectors
into the Lentiviral backbone containing the GFP repair
fragment (Supplementary Figure S1b). ORFs were ligated
in frame with a self-cleaving T2A peptide sequence,
followed by a blue ﬂuorescent protein, mTagBFP, to
allow expression levels to be measured. On Day 0,
1 10
5 HEK cells of each reporter cell line were plated.
On Day 1, each reporter cell line was transfected with
400ng of LHE expression/repair plasmid with poly-
ethylenimine at a wt/wt ratio of 4:1 in a pH 7, 150mM
NaCl, 5mM HEPES buffer. Cell medium was replaced on
day 2, and cells were allowed to accumulate conversion
events until Day 4, when they were analyzed by ﬂow
cytometry on a BD LSRII
TM. Using FloJo software,
each expressing population was deﬁned by mTagBFP
ﬂuorescence. GFP
+ and mCherry
+ statistics, representing
HR and mutagenic non-homologous end-joining events,
respectively, were tabulated for these populations.
mTagBFP positivity was determined in comparison with
non-transfected cells for each cell line; GFP and mCherry
in comparison with non-expressing populations in the
transfected cells. To ensure that the non-expressing popu-
lation was truly not expressing the construct, a small
number of the highest mTagBFP-low cells were excluded
from the non-expressing population.
Protein expression and puriﬁcation
The IHjeMI reading frame was ligated into a commer-
cially available pET15b expression plasmid (Novagen,
Inc) that incorporates an N-terminal 6-histidine afﬁnity
puriﬁcation tag and subsequent thrombin cleavage site
prior to the endonuclease reading frame. One-point
mutation was incorporated into the I-HjeMI coding
sequence (corresponding to L232K), based on the know-
ledge that a similar mutation at that position increases the
solubility of the homologous I-AniI (19). The I-AniI con-
struct used for parallel expression experiments under the
same conditions was as described previously (20). Both
I-HjeMI and I-AniI constructs were expressed in
Escherichia coli strain BL21-CodonPlus (DE3)-RIL
(Stratagene Inc.), using a method described previously
for automatic induction of protein expression (21).
Harvested cells were collected by centrifugation, resus-
pended in 500mM NaCl, 50mM Tris–HCl, pH 8.0, 5%
glycerol with 0.2mM phenylmethylsulfonyl ﬂuoride and
benzonase and lysed by sonication. After a second centri-
fugation step, the clariﬁed cell lysate was ﬁltered (45m pore
size), puriﬁed using a single Heparin afﬁnity puriﬁcation
chromatography step (HiTrap Heparin HP, GE
Healthcare Life Sciences) and eluted with an increasing
gradient of 0.5–1.0M NaCl (Supplementary Figure S2).
The resulting protein was exchanged into thrombin
cleavage buffer and the N-terminal His-tag was proteo-
lytically removed. The homing endonuclease protein was
then puriﬁed from the thrombin cleavage products by
incubating the sample with nickel-NTA agarose resin (to
bind the cleaved histidine tag and linked fusion polypep-
tide), followed by size exclusion chromatography.
Crystallographic analysis
The DNA oligonucleotides used for cocrystallization
(50-GCG CTG AGG AGG TTT CTC TGT TAA GCG
A-30 and 50-CGC TTA ACA GAG AAA CCT CCT CAG
CGC T-30) were synthesized by Euroﬁns MWG Operon
Inc (desalted; 50nmol scale syntheses). The oligonucleo-
tides were dissolved in 10mM Tris–EDTA buffer pH 7.8,
to a ﬁnal concentration of the resulting DNA duplex of
1mM, and the complementary DNA strands were
annealed by incubation at 95 C for 5min and cooling to
25 C, over a 2-h period. Puriﬁed I-HjeMI protein
described above was mixed with 1.2-fold molar excess of
the DNA substrate for a ﬁnal concentration of 4.5mg/ml
protein, in the presence of 1mM CaCl2, 400mM NaCl
and 50mM Tris–HCl. The protein–DNA drops were
mixed in a 1:1 volume ratio with a reservoir solution con-
taining 0.2M ammonium sulfate, 0.1M bis–Tris pH 5.5
and 25% polyethelylene glycol 3350. Crystals grew within
1 week and were frozen by transfer for 1–2min to crystal-
lization reservoir solution supplemented with 30% sucrose
(w/v), followed by direct submersion into liquid nitrogen.
The space group of the crystals corresponded to P21212;
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up to  2.5A ˚ resolution at the ALS beamline 5.0.2
(Lawrence Berkeley National Laboratory). Data sets
were processed using the HKL2000 software package
(22). The structure of the I-HjeMI/DNA complex was
solved by molecular replacement using the protein data
bank (PDB) coordinates of the WT I-AniI/DNA
complex (PDB: 2QOJ), and was modeled using COOT
(Crystallography Object-Oriented Toolkit) (23) and
reﬁned using REFMAC/CCP4i (24). Due to signiﬁcant
disorder displayed by one of the two independent copies
of the protein–DNA complex in the crystal asymmetric
unit (which resulted in poor reﬁnement statistics across
the upper resolution shells), the ﬁnal modeling and reﬁne-
ment was carried out to 3A ˚ resolution. While the values
for Rwork and Rfree were still elevated at this resolution
(0.28/0.36), the quality of all other reﬁnement metrics
and the ﬁt of the well-ordered complex to experimental
electron density were excellent.
RESULTS
Identiﬁcation of I-AniI homologs and their target sites
To identify LHE-coding sequences homologous to
I-AniI, the National Center for Biotechnology Infor-
mation ‘tblastn’ function was used to identify multiple
putative LHEs of varying similarity in public sequence
databases. Six homologs, each identiﬁed in different
fungal mitochondrial genomes, and whose alignments
are shown in Figure 1A, were selected based on the con-
servation of catalytic Mg
+ +-coordinating residues within
the LAGLIDADG motif to increase chances of ﬁnding
an active LHE. The introns containing these putative
LHEs also had ﬂanking sequences differing from
I-AniI, suggesting slightly altered cleavage speciﬁcities
(25,26) (Figure 1B). These homologs were named accord-
ing to the conventions put forth by Roberts et al. (27);
notably, a ‘P’ sufﬁx denotes a homolog of unveriﬁed en-
zymatic functionality. The additional sufﬁx M was added
to avoid redundancy in nomenclature relative to previous-
ly identiﬁed restriction or homing endonucleases, and to
also denote that the host genome that harbored the LHE
gene was mitochondrial. Figure 1C shows the putative
target sequences of the six homologs as determined by
the comparison of the sequence ﬂanking the LHE
insertion, where the I-AniI target sequence is found.
Assessment of nuclease functionality
Yeast surface display represents a convenient method for
characterizing putative LHEs in high throughput, as it
provides facile access to quantitative information on
protein folding and stability, DNA binding and
cleavage, without the need for large scale enzymatic puri-
ﬁcation (17,28). In this approach, the enzyme is fused to
an inducible surface displayed protein, Aga2p, which is
anchored to the yeast’s exterior by two disulﬁde bonds
(29). Transit through the ER quality control and secretory
pathways helps ensure that only LHEs which are stably
folded at the induction temperature (20–30 C) are
expressed on the yeast surface; dysfunctional variants
which do not fold correctly are retained in direct propor-
tion to their thermal stability (30). To compare the
properties of six of the closest I-AniI homologs identiﬁed
in Figure 1, yeast codon optimized ORFs were
synthesized (Supplementary Table S1) and subcloned to
the pCTCON2 vector. Relative expression levels were
Figure 1. Predicted homologs and targets. (A) The alignment of the I-AniI homologs with the residues shaded by chemical similarity. LAGLIDADG
motifs are marked by waved lines. Conserved Mg
+ +-coordinating residues and DNA-contact rich strand-turn-strand regions are also annotated. The
homologous serine 111, a residue important for increased catalytic activity in I-AniI, is starred. The map was generated by MacVector using
Gonnet-weighted pairwise and multiple sequence alignments with residue-speciﬁc and hydrophilic penalties. Residue numbering was matched to
I-AniI, based on the ﬁrst LAGLIDADG motif. (B) Schematic depicting the original host gene (black) with intron insertion (white) from which the
LHE ORF sequences were taken and the exon/intron junctions used to predict target sequences (gray). (C) Predicted targets for each homolog,
derived by comparing ﬂanking intron/exon regions for each intronic LHE with those from I-AniI; differences therefrom are shaded.
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and C-terminal myc epitope tags (28,30) (Figure 2A).
Three of the six homologs, I-AchMI, I-HjeMI and
I-PnoMI, expressed full-length proteins on the yeast
surface; the latter two very well, as determined by the
level of C-terminal epitope tag expression (Figure 2B).
I-TasMIP, I-TinMIP and I-VinIP surface expressed
poorly, presumably because they were insufﬁciently
stable at the 30 C induction temperature. Consistent
with this interpretation, poor surface expression corre-
lated with the accumulation of heterogeneously truncated
proteins containing only the N-terminal tag, a pattern
conﬁrmed by western blot of the surface released protein
(Figure 2C) and congruent with previous observations of
surface-expressed proteins of low thermostability (31–34).
Notably, the level of surface expression correlated with the
level of amino acid sequence homology to I-AniI
(Supplementary Figure S3).
The three homologs with detectable surface expression,
I-AchMI, I-PnoMI and I-HjeMI, were further assayed for
binding and cleavage properties using ﬂuorescently
labeled oligonucleotide containing the predicted target
site. Each bound their predicted native target with
similar afﬁnity to I-AniI (Supplementary Figure S4).
Cleavage analysis was assessed using a previously
described tethered oligonucleotide assay (17,20), depicted
in Supplementary Figure S5, wherein enzyme and sub-
strate levels were normalized (Figure 2D). I-HjeMI and
I-PnoMI demonstrated catalytic activity against their
putative DNA target sequences at levels comparable
with, or slightly greater than, that of I-AniI against its
target; I-AchMI showed a reduced level of activity
(Figure 2E). Each enzyme’s ability to speciﬁcally cleave
its substrate was also evaluated with a solution-type
assay following release of yeast surface expressed protein
to validate the ﬂow cytometry (Supplementary Figure S6).
Figure 2. LHE characterization by ﬂow cytometry. (A) Expression of full-length protein, determined by ﬂow cytometry in a representative experi-
ment. Staining against a C-terminal epitope tag and associated measured ﬂuorescence intensity (Y-axis) and N-terminal epitope tag (X-axis) allows
qualitative and quantitative assessment of surface expression. I-TasMIP, I-TinMIP and I-VinIP show minimal full-length protein (quadrant I and
dual-positive), indicating reduced thermostability and/or poor folding. (B) Percentage of expressing (dual-positive) cells, as in panel (A), is
summarized for ﬁve replicates (three for I-TasMIP, I-TinMIP and I-VinIP) with standard deviation plotted. (C) A western blot using antibodies
against the N-terminal epitope tag allowed visualization of full length and truncated protein. Much of I-AchMI was expressed as  33kDa protein
fragment. Only minimal full-length protein and primarily heterogeneously truncated I-TasMIP, I-TinMIP and I-VinIP products were expressed, while
I-Hje, I-PnoMI and I-AniI were primarily full length and in great abundance. (D) Demonstration of the gating strategy used to normalize substrate
for the ﬂow cleavage assay. These displayed populations are already normalized for enzyme concentration by a uniform, narrow FITC (C-terminal
epitope) gate (data not shown). Equivalent amounts of tethered dsOligo across samples was selected by ﬁnding a streptavidin–PE level (rectangle) for
each sample for which all DNA-A647 median ﬂuorescence intensities (dashed horizontal line) were equal in the Ca
+ + sample (blue population). This
gate was held constant for the matched pair Mg
+ + sample (red population), allowing quantiﬁcation of magnesium-dependent loss of the
DNA-conjugated ﬂuorophore. The left half of the plot shows the population in the rectangular PE gate from the right plot (follow arrow).
(E) Dividing the median Alexa647 ﬂuorescence intensity of the calcium-containing sample (blue) by that of the magnesium-containing sample
(red) yields a ratio proportional to the amount of enzymatic activity for a given LHE.
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The above data indicate that an appreciable fraction of
raw LHE ORFs identiﬁed in public databases by sequence
similarity possess potentially useful enzymatic activities.
To compare the biochemical properties of these enzymes
in more detail, a ‘one-off’ cleavage speciﬁcity proﬁle was
determined for WT I-AniI and each of the two highly
active enzymes, I-HjeMI and I-PnoMI, using the yeast
tethered DNA cleavage assay (Figure 3). In this assay, a
panel of DNA substrates, each harboring a single base
pair mismatch relative to the LHE’s physiological target,
are assessed for relative cleavability by the expressed
enzyme. This assessment revealed that, as expected,
I-HjeMI and I-PnoMI exhibit overall I-AniI-like proﬁles
with localized variances in positions where their predicted
targets sites differ from that of I-AniI. For example,
I-HjeMI exhibited elevated speciﬁcity at position  2
compared with the other two enzymes, but reduced speci-
ﬁcity at  8, and to a lesser extent,  7 and  6, while
I-PnoMI preferred a ‘T’ at  5, one of the two differences
in its cognate target from I-AniI. Some small idiosyncratic
differences were also observed, such as I-HjeMI preferring
a ‘G’ at the  5 position, despite the fact that its predicted
native target site has an ‘A’.
We also assessed the potential for ‘end holding’, a
property in which one DNA half-site is bound (and
retained after cleavage) with particularly high afﬁnity by
the LHE when compared with the opposing half-site. This
behavior is particularly notable for I-AniI and has been
exploited for computational design purposes (14). Similar
to I-AniI, both I-HjeMI and I-PnoMI were found to
’end-hold’ the minus (or left) half of their DNA substrates
(Supplementary Figure S7). This asymmetric pattern
suggests that these homologs use a similar nucleotide dis-
crimination mechanism to I-AniI (14), consistent with the
high conservation of amino acid identity in the protein/
DNA interface among the three enzymes in the beta
sheets regions of the strand-turn-strand domains (20)
(Figure 1A).
In vivo LHE activity
The three enzymes that exhibited detectable surface
expression and cleavage activity (I-AchMI, I-PnoMI and
I-HjeMI) were also assayed for their potential for
Figure 3. Speciﬁcity proﬁles for (A) I-HjeMI, (B) I-PnoMI and (C) I-AniI. The impact of each possible single-base pair substitution is shown relative
to wild-type cleavage efﬁciency (red dashed line, wild-type base noted above). Values at or close to zero denote minimal tolerance of the mismatch
and therefore minimal cleavage, while values above one indicate a target is cleaved more efﬁciently than the predicted target.
Nucleic Acids Research, 2012,Vol.40, No. 11 4959endogenous DNA targeting and genome engineering using
a reporter system in a human cell line. For this purpose, a
recently described reporter system (18) was used to deter-
mine the relative ability of each LHE to induce mutagenic
non-homologous end-joining (NHEJ) or HR, key genome
engineering events. The reporter system is comprised of
two parts: a chromosome-embedded reporter and an
endonuclease expression and repair template vector
(Supplementary Figure S1). If a break is generated in
the reporter, it can be repaired by HR using the
template GFP sequence to restore a functional GFP
protein and the cell will be green. If the break is
repaired by mutagenic NHEJ with a frameshift to the
+3 reading frame, the GFP will be read-through and the
mCherry will now be properly translated in-frame,
producing a red cell. Nuclease expression and donor
delivery is tracked by a blue ﬂuorescent protein linked in
translation via a T2A self-cleaving sequence.
To implement the assay, polyclonal cell lines were
generated which harbored integrated single copies of re-
porters possessing each respective enzymes’ target site.
Next, each of these cell lines were transfected with equal
amounts of a donor template plasmid which also drives
expression of the respective homing endonuclease. This
resulted in similar distributions and sums of nuclease ex-
pression and repair template copy number, as assessed by
the expression (ﬂuorescence) of a monomeric blue ﬂuores-
cent protein, mTagBFP (Figure 4A). I-AchMI exhibited
little to no in vivo activity, consistent with its poor per-
formance in the yeast tethered ﬂow cleavage assay—this
may reﬂect either an actual reduced catalytic efﬁciency, or
that an impaired protein folding and/or thermal stability
limits accumulation of active enzyme in cells cultured at
37 C. For these reasons, I-AchMI should be considered a
compromised engineering scaffold for in vivo applications.
In contrast, I-PnoMI and especially I-HjeMI,
demonstrated repair of the GFP reporter by HR at
frequencies much higher than native I-AniI and compar-
able with the previously reported increased activity variant
Y2-Ani (35) (Figure 4B and C). Furthermore, remarkably
high levels of mutagenic NHEJ were observed for I-HjeMI
in the trafﬁc light reporter assay: levels  3-fold higher
than those stimulated by Y2-Ani and I-PnoMI. Thus,
biotechnologically relevant activities appear to vary sub-
stantially among this group of closely related proteins.
I-HjeMI crystal structure
Based on I-HjeMI’s enhanced in vitro and in vivo function-
al properties, we were curious whether it might possess
structural differences from I-AniI that could be identiﬁed
and correlated with its performance characteristics. Thus,
we expressed I-HjeMI in bacteria, puriﬁed it to homogen-
eity and placed it into crystallization trials using a
spectrum of standard conditions. In striking contrast to
I-AniI, which we have found to be prone to chronic ag-
gregation that required multiple solubilizing mutations to
ameliorate, I-HjeMI was easily produced in large
quantities and remained soluble, even at a 20mg/ml con-
centration of the puriﬁed protein. The structure of the
resulting complex of I-HjeI bound to its DNA target
was determined at 3.0A ˚ resolution.
Two separate copies of the I-HjeMI/DNA complex are
found within the asymmetric unit of the crystal form as
described in ‘Materials and Methods’ section. One of the
complexes (corresponding to protein ‘chain A’ and DNA
‘chains B and C’ in the resulting model) was extremely well
ordered, and displayed crystallographic packing contacts
in which the overhanging A and T bases of the DNA
duplex formed a continuous, Watson–Crick matched
pseudocontinuous helix. The density for the entire
complex (with the exception of several disordered
residues in the linker that connects the two protein
domains) was very clear, and the resulting model
Figure 4. LHE functionality in vivo.( A) Nuclease-expression histogram. Number of cells (Y-axis) of a given mTagBFP ﬂuorescence (X-axis) are
shown to be uniform for all transfected cells (solid line) and are compared with an untransfected control (dashed line). Gates used for comparison of
expressing and non-expressing populations in panel (B) are shown. (B) Mutagenic NHEJ and HR repair events are shown for each
nuclease-expressing population (black) compared with the non-expressing (gray). NHEJ events are mCherry(+) (Y-axis) and HR events are
GFP(+) (X-axis). (C) As each mCherry(+) cell represents approximately one-third of the actual mutagenic NHEJ events (18) (Supplementary
Figure S1d), a corrected value is plotted for NHEJ events, calculated by multiplying the number of mCherry(+) cells by three. Cells with converted
loci, by event type, are shown as a percentage of the total expressing population.
4960 Nucleic Acids Research, 2012,Vol.40, No. 11displayed excellent Ramachandran distribution and
equally outstanding correlation to the density maps
(Supplementary Figure S8). However, the second copy
of the complex (corresponding to protein chain B in the
resulting model) was very poorly ordered and displayed
obvious clash at the ends of neighboring crystallographic-
ally related DNA molecules that resulted in a disruption
of the base pairing at both ends of the duplex. As a result,
the overall ﬁt of the model to the second copy of the
complex was of much lower quality. The poor quality of
density across the second copy of the complex and the
equally challenging model ﬁt to that density preventing
the overall reﬁnement R-factors from being reduced to
their usual acceptable values (Rwork and Rfree correspond
to 0.28 and 0.36, respectively, see Table 1). However, the
high sequence identity (85%) of I-HjeMI to the I-AniI
homing endonuclease [which has previously been solved
and reﬁned in multiple independent space groups to high
resolution (19,20,35)] and the excellent quality of electron
density for the well-ordered complex of I-HjeMI to its
DNA target nevertheless allowed us to generate an unam-
biguous comparison of the structures of the two homolo-
gous homing endonucleases (Figure 5). The results below
are based on the analysis of only the well-ordered complex
of I-HjeMI.
As expected, I-HjeMI displays a very similar overall
structure to the structure of I-AniI (Figure 6), except for
the few ﬁnal residues of their C-termini and a short region
of extended peptide sequence (spanning residues 123–129
in I-HjeMI) that links the N-terminal and the C-terminal
domains of the two enzymes. The regions of folded sec-
ondary structure across the two enzymes and in particular
the two central a-helices that contain the ‘LAGLIDADG’
sequence motifs, are closely superimposable [root mean
square deviation (RMSD) less than 1A ˚ between all
a-carbons] while the overall RMSD for all a-carbons
across the superimposed proteins is  1.6A ˚ . The overall
bend angles of the DNA and the geometric values of in-
dividual base pairs (i.e. propeller twist, roll, etc.) in the
I-HjeMI and I-AniI complexes were also very similar.
Of the 37 amino acid substitutions that distinguish
I-HjeMI from I-AniI, 11 are located in the N-terminal
folded domain (residues 1–110), 18 are located in the
C-terminal domain (residues 126–254) and 8 are located
in the linker that connects the two (residues 111–125). Of
those substitutions, none are located in the
LAGLIDADG helices and very few are buried in the
hydrophobic core (the exception being I212, I213, L215
and L235 in the core of the I-AniI C-terminal domain,
which are instead V212, V213, I216 and I235 in
I-HjeMI). The remainder of amino acid differences
involves residue positions that are partially or fully
surface accessible. Four substitutions appear to involve
residues that are involved in DNA contacts: I55, S111,
R172 and K200 in I-AniI are instead K55, Y111, K172
and R200 in I-HjeMI. Of these substitutions, two (I55K
and S111Y) result in additional nonspeciﬁc contacts to the
DNA backbone, one (R172K) appears to have little effect
on the structural mechanism of DNA recognition, and one
(K200R) involves a side chain that appears to make
contacts to nucleotide bases in the DNA target site
Figure 5. I-HjeMI model and electron density map. There is
high-quality density (blue mesh) in the well-ordered complex around
(A) R202 (K200 in Ani) and (B) Y113 (Y111 in Ani).
Table 1. Data collection and reﬁnement statistics
Data collection
ALS beamline BL5.0.1
Wave length (A ˚ ) 1.00000
Space group P21212
Unit cell dimension (A ˚ ) a=181.6, b=73.6, c=82.0,
Asymmetric unit content Two complexes
Total reﬂections 85960
Unique reﬂections 22491
Resolution (A ˚ )
a 50.00–3.00 (3.11–3.00)
Completeness (%)
a 98.4 (94.5)
Redundancy
a 3.9 (3.6)
Rmerge
a,b 0.046 (0.088)
Average I/sI
a 22.8 (13.8)
Reﬁnement
Rwork (%)
c 0.28
Rfree (%)
c 0.36
Protein residues 504
Nucleotides 112
Water molecules 175
Metal ions 5 Ca
+ +
RMSD bond length (A ˚ ) 0.0103
RSMD bond angle ( ) 1.704
Ramachandran
distribution (%)
90% preferred, 7% allowed,
3.0% outliers
Ramachandran distribution
(Copy A)
93% preferred, 6% allowed,
1% outliers
Average B-factors (A
2) 24.5
aHighest resolution shell values in parenthesis.
bRmerge=|Ihi <Ih>j/Ih, where Ihi is the ith measurement of reﬂec-
tion h, and <Ih> is the average measured intensity of reﬂection h.
cRwork/Rfree=hjFh(o) - Fh(c)j/hjFh(o)j, where Rfree was calculated with
5% of the data excluded from reﬁnement.
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to  4A and  5G on one strand of the DNA target). The
substitution of a tyrosine for serine at residue 111 (S111Y,
which results in a nonspeciﬁc interaction to the DNA
backbone outside of the 22 base pair target site) corres-
ponds to a mutation that was previously introduced into
I-AniI during a selection experiment for improved
cleavage of its own wild-type target site (35).
DISCUSSION
This study demonstrates that a survey of evolutionary
sequence space around a speciﬁc LHE is able to rapidly
identify variants with a range of desirable properties for
gene targeting applications. These enzymes displayed
varying levels of thermostability, solubility,
crystalizability, cleavage activity and capacity to induce
different rates of site speciﬁc genetic alterations when
expressed in a human cell line. These results highlight
the considerable utility of surveying evolutionarily infor-
mation as a supplement to rational protein engineering of
novel LHE variants with speciﬁc properties.
The use of yeast surface display allowed multiple
properties of each LHE ORF to be rapidly assessed,
including thermal stability, binding and cleavage
activity. Importantly, enzymes whose surface expressed
well and exhibited signiﬁcant activity in the tethered
cleavage assay tended to perform very well in vivo, the
notable exception being the originally described family
member, I-AniI. Additionally, by combining an initial
yeast surface display assessment with an in vivo reporter
assay, we were able to identify two new enzymes that
exhibit in vivo performance on par or better than
Y2-Ani—an engineered variant speciﬁcally identiﬁed to
have improved cleavage properties (35). As engineering
attempts to modify an LHE’s target speciﬁcity are often
associated with reductions of catalytic efﬁciency toward
the new target site, the availability of scaffolds with
improved in vivo performance may provide both
optimized starting points for engineering, as well as infor-
mation on protein modiﬁcations that can be made to
improve the performance of engineered variants. Further-
more, I-HjeMI’s high solubility and crystalizability
allowed rapid structural analysis, which can be a
powerful tool when compiling many changes to a
scaffold (6).
We chose our original search parameters to include
both highly related homologs and those exhibiting
locally altered substrate speciﬁcities, with the goal that
sequence information from related scaffolds with differing
speciﬁcities would help to inform engineering of the
scaffolds to cleave new target sites. As exempliﬁed in a
contemporaneous work by Szeto et al. (36), small
speciﬁcity-determining pockets which have been evolu-
tionarily selected can be elucidated by comparing
homologs at places of divergent sequence speciﬁcity, and
these changes can be grafted onto related enzymes.
In addition to revealing locally altered substrate
speciﬁcities and activities, evolutionary sequence informa-
tion may also help to inform us about the plasticity of
enzymes at certain positions. This idea is supported by
the improved speciﬁcity (versus I-AniI) that we observed
at position  2 for I-HjeMI, the improved speciﬁcity of
I-PnoMI at  8 relative to I-HjeMI and the reverse rela-
tionship at the position+5. Therefore, these locations may
be identiﬁed as particularly amenable to modiﬁcation,
thus facilitating protein engineering of the scaffold group.
An interesting question raised by our results that
warrants further investigation is whether there are distin-
guishing features of those proteins that did not surface
express well or perform well in vivo, or those that per-
formed exceptionally well. Strikingly, I-HjeMI and
I-PnoMI natively harbor a tyrosine at the position analo-
gous to 111 in I-AniI, one of two changes in Y2-AniI
identiﬁed by directed evolution to signiﬁcantly enhance
the activity of the original I-AniI enzyme (28). As polar
surface residues have been found to play critical roles in
protein folding and stability (37–40), we generated
homology models of the six I-AniI homologs analyzed
Figure 6. Structure of I-HjeMI. The solved structure of I-HjeMI
(green) is shown bound to its target DNA (gray). This structure has
been aligned to that of I-AniI (cyan) with differences highlighted red.
4962 Nucleic Acids Research, 2012,Vol.40, No. 11here and used them to predict surface exposed residues.
Consistent with the importance of these residues in
promoting stable folding, I-HjeMI, I-PnoMI and
I-AniI-I were predicted to possess fewer overall
solvent-exposed hydrophobic residues outside of the
protein–DNA interface (19,19,21) than any of I-VinIP,
I-TasMIP and I-TinMIP (24,23,25). Incorporation of
such analysis may allow to rapidly pare down a list of
homologous LHE’s identiﬁed in public sequence data-
bases to those most likely to possess biotechnologically
relevant or other positive attributes.
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